Replies to post #36167 on Biotech Values

[DewDiligence]

>they said enrollment picking up was the reason.<

That’s another valid reason to forego an interim look, but it’s one that rarely occurs in practice. It’s much more common for a company to overestimate the speed of enrollment than to underestimate it.